The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2018-03-01
Cyfres:Pharmacogenomics and Personalized Medicine
Pynciau:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Mynediad Ar-lein:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg